Josh McGovern

11PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersSport and exercise nutritionFood properties (incl. characteristics and health benefits)Cancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 09, 2025
Does Modified 5-Item Frailty Index Correlate With Survival in Oropharyngeal Squamous Cell Carcinoma?

Marta Chmielecka, Rhona Hurley, Mohd Afid Mohd Slim

|Sep 25, 2024
RE: Exercise and Nutrition to Improve Cancer Treatment-Related Outcomes (ENICTO).

Josh McGovern, Ross D Dolan, Richard J E Skipworth

|Aug 21, 2024
The prevalence and prognostic value of systemic inflammation in good performance status patients with advanced, inoperable non-small cell lung cancer receiving palliative radiotherapy: Comparison of composite ratios and cumulative scores.

Josh McGovern, Fraser O'Rourke, Sarah Will

|Mar 27, 2024
The Relationship between Liver Volume, Clinicopathological Characteristics and Survival in Patients Undergoing Resection with Curative Intent for Non-Metastatic Colonic Cancer.

Josh McGovern, Charles Mackay, Rhiannon Freireich

|Mar 12, 2024
Comment on "A promising prognostic grading system incorporating weight loss and inflammation in patients with advanced cancer" by Zhang et al.

Josh McGovern, Donald C McMillan

|Dec 13, 2023
The relationship between clinicopathological variables, systemic inflammation, and CT-derived body composition with survival in patients with advanced non-small cell lung cancer receiving nivolumab as a second-line treatment.

Randa Saeed, Josh McGovern, Hugo Bench

Pageof 2

Frequent Collaborators

5 joint publications

Ross D Dolan

3 joint publications

Donald C McMillan

1 joint publications

Randa Saeed

1 joint publications

Barry J A Laird